Leverage advanced methodologies to integrate imaging, single cell RNA-seq and deep immunoglobulin repertoire sequencing to dissect molecular mechanisms regulating B cell fate...
Identifying specific vulnerabilities in chemoresistant lymphomas and leukemias to develop novel synthetic lethality-based therapies, with a focus on MYC, BCL-2, MCL-1, and DNA...